Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here Are Billionaire Jeff Ubben’s New Positions and Top Bullish Moves

Page 1 of 2

Jeffrey Ubben founded ValueAct Capital in 2000. The California-based hedge fund has recently filed its 13F filing, in which it disclosed its equity portfolio worth $11.02 billion as of the end of June. Mr. Ubben has worked as a managing partner at Richard Blum’s Blum Capital Partners before starting his own hedge fund. In 2013, Ubben got a seat on Microsoft’s board despite having a paltry position. Mr. Ubben also oversees The Posse Foundation, a nonprofit organization that trains student leaders from public high schools to form multicultural teams.

ValueAct’s investment strategy initially was to focus on valuation and quality discipline, but after the financial crisis of 2008, ValueAct started catering for a vast array of metrics like capital allocation, acquisitions, budgeting and compensation. ValueAct generally makes only three to four new investments in a year, and is famous for its long-term vision. It often holds about 15 positions and the average holding period for each position is about three years. In this article, let’s take a look at some stocks, in which ValueAct boosted its position during the second quarter.

Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that imitating the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012 (read more details here).

VALUEACT CAPITAL

Baker Hughes Incorporated (NYSE:BHI)

– Shares Owned by ValueAct Capital (as of June 30): 38.89 million

– Value of ValueAct Capital’s Holding (as of June 30): $1.75 billion

Jeffrey Ubben’s ValueAct Capital added over 15.63 million shares of the oilfield services company to its equity portfolio during the three-month period from April-June, increasing its hold in the company by 67%. The total position now accounts for a whopping 16% of the hedge fund’s equity portfolio. Earlier this month, Baker Hughes Incorporated (NYSE:BHI) announced rig count for July which stood at 938, 11 units better than a month earlier.  The Texas-based company missed second-quarter earnings estimates, having reported a net loss of $0.90 per share, versus estimates of a loss of $0.68, but revenue of around $2.40 billion, was $80 million above expectations. Shares of Baker Hughes are up by almost 10% so far in 2016. As of the end of the second quarter, Natixis Global Asset Management’s Harris Associates owns over 4.7 million shares of Baker Hughes.

Follow Baker Hughes Inc (NYSE:BHI)
Trade (NYSE:BHI) Now!

Alliance Data Systems Corporation (NYSE:ADS)

– Shares Owned by ValueAct Capital (as of June 30): 3.29 million

– Value of ValueAct Capital’s Holding (as of June 30): $ 644.17 million

ValueAct Capital boosted its stake in Alliance Data Systems Corporation (NYSE:ADS) by some 2.75 million shares during the second quarter. Last month, the Texas-based provider of royalty and marketing solutions reported second-quarter earnings of $3.68 per share on $1.75 billion revenue, crushing estimates of EPS  of $3.59 on $1.64 billion in revenue. The firm expects to earn $16.85 per share in 2016, versus the consensus estimate of $16.78. Shares of Alliance Data Systems have lost over 22% since the start of the year.  Barry Rosensteins JANA Partners owns 675,412 shares of the company as of the end of the second quarter.

Follow Alliance Data Systems Corp (NYSE:ADS)
Trade (NYSE:ADS) Now!

We will continue our discussion of ValueAct Capital’s biggest moves of the second quarter on the next page.

 

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!